|
Sino Biological
mouse Mouse, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/HCoV-OC43+Spike+Antibody%2C+Mouse+MAb/bio_rxiv__64898__2026__02__27__708290-254-44-49 Average 94 stars, based on 1 article reviews
mouse - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
anti spike ![]() Anti Spike, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Rabbit+IgG+Anti+HCoV-OC43+Spike+(S1)+Polyclonal+Antibody/bio_rxiv__64898__2026__02__27__708290-249-25-27 Average 94 stars, based on 1 article reviews
anti spike - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Sino Biological
antibodies against hcov oc43 n ![]() Antibodies Against Hcov Oc43 N, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+(HCoV-OC43)+Nucleocapsid+Antibody%2C+Rabbit+PAb%2C+Antigen+Affinity+Purified/pm41773861-59-0-11 Average 95 stars, based on 1 article reviews
antibodies against hcov oc43 n - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Sino Biological
40607 v08h1 hcov hku1 spike protein s immune tech ![]() 40607 V08h1 Hcov Hku1 Spike Protein S Immune Tech, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+(HCoV-OC43)+Spike+S1+Protein/10__2139_slash_ssrn__3950749-291-126-123 Average 93 stars, based on 1 article reviews
40607 v08h1 hcov hku1 spike protein s immune tech - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Medix Biochemica
hcov oc43 ![]() Hcov Oc43, supplied by Medix Biochemica, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Anti-hCoV+OC43+3505+SPTN-5/pmc07088225-51-8-14 Average 90 stars, based on 1 article reviews
hcov oc43 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sino Biological
hcov oc43 spike Figure S6 . " width="250" height="auto" />Hcov Oc43 Spike, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+(HCoV-OC43)+Spike+Protein/pmc08106889-34-0-3 Average 94 stars, based on 1 article reviews
hcov oc43 spike - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Sino Biological
mouse monoclonal antibodies against sars cov 2 rbd ![]() Mouse Monoclonal Antibodies Against Sars Cov 2 Rbd, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Coronavirus+(SARS-CoV-2%2C+SARS-CoV%2C+MERS-CoV%2C+HCoV-HKU1%2C+HCoV-OC43)+Spike+Antibody%2C+Mouse+MAb/pmc09981790-204-13-19 Average 93 stars, based on 1 article reviews
mouse monoclonal antibodies against sars cov 2 rbd - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Sino Biological
hcov oc43 ![]() Hcov Oc43, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+OC43+(HCoV-OC43)+Nucleocapsid+%2F+NP+Gene+ORF+cDNA+clone+expression+plasmid/pmc09974210-39-0-10 Average 93 stars, based on 1 article reviews
hcov oc43 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Sino Biological
n his protein ![]() N His Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+(HCoV-OC43)+Nucleocapsid+Protein/pm37399385-265-43-46 Average 93 stars, based on 1 article reviews
n his protein - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Sino Biological
oc43 cov ![]() Oc43 Cov, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+(HCoV-OC43)+Spike+Gene+ORF+cDNA+clone+expression+plasmid(Codon+Optimized)%2C+C-Flag+tag/pm37991919-274-6-20 Average 93 stars, based on 1 article reviews
oc43 cov - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Sino Biological
aa16 ![]() Aa16, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hcov+oc43/Human+coronavirus+(HCoV-OC43)+Hemagglutinin+esterase+Protein/pmc07239054-23-15-12 Average 92 stars, based on 1 article reviews
aa16 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: A stable subgenomic reporter coronavirus enables transcriptional profiling of bystander cells
doi: 10.64898/2026.02.27.708290
Figure Lengend Snippet: Reagents for analysing HCoV-OC43. A. Western blot of Mv.1.Lu cells infected with HCoV-OC43 at an MOI of 10 PFU/cell and harvested at the indicated time points, probed with two anti-Nucleocapsid (N) antibodies, derived from Sheep (Sh) polyclonal antiserum from the MRC PPU & CVR Coronavirus toolkit and a commercial Rabbit (Rb) polyclonal antiserum. Host HSP90 is included as a loading control. B . Immunofluorescence microscopy of HCoV-infected A549 cells, stained with Sheep anti-N and anti double-stranded RNA (dsRNA), a marker of RNA replication. C . Immunoprecipitation (IP) of lysates from HCoV-OC43-infected cells (MOI 3, 24 hpi) using Sheep anti-N and probed with Sheep anti-N and anti-Spike (S). Host HSP90 is included as a loading control. D . Immunofluorescence microscopy of HCoV-OC43-infected A549 cells, stained with mouse monoclonal (Mm) or rabbit polyclonal (Rb) anti-S. E . Silver stain (SS) and western blotting (WB) of virions purified by ultracentrifugation through a 30% sucrose cushion. The supernatant (sup) before and after sucrose cushion, and the pellet, containing purified virions, are shown. Viral structural proteins are indicated by red arrowheads and BSA from cell culture medium by a red asterisk. F . Immunofluorescence microscopy of HCoV-OC43-infected A549 cells stained with anti-SARS-CoV M. Scale bars represent 10 µm.
Article Snippet: Membranes were probed with sheep polyclonal anti-Nucleocapsid anti-serum (MRC PPU & CVR Coronavirus Toolkit, Sheep No. DA116, 1:1000) , rabbit anti-Nucleocapsid (40643-T62, Sino Biological, 1:1000),
Techniques: Western Blot, Infection, Derivative Assay, Control, Immunofluorescence, Microscopy, Staining, Marker, Immunoprecipitation, Silver Staining, Purification, Cell Culture
Journal: Mikrochimica Acta
Article Title: An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes
doi: 10.1007/s00604-019-3345-5
Figure Lengend Snippet: a Optimization of MERS-CoV antibody concentration, b Effect of MERS-CoV immunosensor binding time between antibody and immobilized antigen. c Effect of HCoV immunosensor binding time between antibody and immobilized antigen. n = 3
Article Snippet: Antigen of HCoV (Oc43 N) and antibody for
Techniques: Concentration Assay, Binding Assay
Journal: Mikrochimica Acta
Article Title: An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes
doi: 10.1007/s00604-019-3345-5
Figure Lengend Snippet: a SWV before and after the competition step of MERS-CoV immunosensor and b SWV before and after the competition step of HCoV immunosensor. The calibration plots were based on the % change of the SWV peak currents (I o -I)/I o %, where I o is current measured at the antigen-modified electrodes after blocking with 1% BSA and I is the current measured after incubation with the sample mixed with the antibody, versus the logarithm of the different concentrations of MERS-CoV ( c ) or HCOV ( d ) antigens. n = 3, the current of the calibration plot was acquired at −0.05 V
Article Snippet: Antigen of HCoV (Oc43 N) and antibody for
Techniques: Modification, Blocking Assay, Incubation
Journal: Mikrochimica Acta
Article Title: An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes
doi: 10.1007/s00604-019-3345-5
Figure Lengend Snippet: a MERS-CoV immunosensor response against 10 ng.mL −1 of MERS-CoV, Flu A, Flu B and control electrode. b HCoV immunosensor response against 10 ng.mL −1 of HCoV, Flu A, Flu B and control. n = 3
Article Snippet: Antigen of HCoV (Oc43 N) and antibody for
Techniques: Control
Journal: Mikrochimica Acta
Article Title: An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes
doi: 10.1007/s00604-019-3345-5
Figure Lengend Snippet: Application of MERS-CoV and HCoV immunosensor in spiked nasal samples. n = 3
Article Snippet: Antigen of HCoV (Oc43 N) and antibody for
Techniques:
Figure S6 . " width="100%" height="100%">
Journal: Cell Reports Medicine
Article Title: Decay of Fc-dependent antibody functions after mild to moderate COVID-19
doi: 10.1016/j.xcrm.2021.100296
Figure Lengend Snippet: Dynamics of dimeric FcγR-binding antibodies against HCoV S antigens in COVID-19 convalescent individuals (A) Best-fit decay slopes of IgG and dimeric FcγR-binding antibodies against S from HCoV strains OC43, HKU1, 229E, and NL63. The responses at time point 1 for each parameter are set to 100%, and the %change over time is shown. (B–E) Kinetics of dimeric FcγRIIIa (V158) and FcγRIIa (H131) binding antibodies against S, S1, or S2 from HCoV strains (B) OC43, (C) HKU1, (D) 229E, and (E) NL63 over time in COVID-19 convalescent individuals (N = 53) measured using the bead-based multiplex assay. The best-fit decay slopes (red lines) and estimated half-lives ( t 1/2 ) are indicated for COVID-19 convalescent individuals. Uninfected controls (N = 33) are shown in open circles, with the median and 90% percentile responses presented as thick and thin dashed lines, respectively. The limit of detection is shown as the shaded area. See also
Article Snippet:
Techniques: Binding Assay, Multiplex Assay
Journal: Cell Reports Medicine
Article Title: Decay of Fc-dependent antibody functions after mild to moderate COVID-19
doi: 10.1016/j.xcrm.2021.100296
Figure Lengend Snippet:
Article Snippet:
Techniques: Infection, Recombinant, Enzyme-linked Immunosorbent Assay, Luciferase, Reporter Gene Assay, Plasmid Preparation, Software
Journal: Frontiers in Immunology
Article Title: Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
doi: 10.3389/fimmu.2023.1066730
Figure Lengend Snippet: In vitro characterization of purified equine immunoglobulin against SARS-CoV-2. (A) The neutralizing titers of hyperimmune serum, purified IgG, and F(ab’) 2 derived from equine No. 15 and No. 16 were tested with wild type SARS-CoV-2 Wuhan 01. The serum neutralizing antibody titer was defined as the reciprocal of the highest dilution showing a 100% CPE reduction compared to the virus control. (B) The titers of purified SARS-CoV-2-specific IgG in equine sera were examined via RBD-capture ELISA. Two repeated tests were performed on each sample.
Article Snippet: Next, the cells were subjected to IFA analysis by using 1,000-fold dilution of
Techniques: In Vitro, Purification, Derivative Assay, Enzyme-linked Immunosorbent Assay
Journal: Frontiers in Immunology
Article Title: Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
doi: 10.3389/fimmu.2023.1066730
Figure Lengend Snippet: Broad-spectrum neutralizing activity test against SARS-CoV-2 VOC and VOI. The neutralizing antibody titers were calculated as the highest dilution of sera that completely inhibited virus-caused CPE. The serum neutralizing antibody titer was defined as the reciprocal of the highest dilution showing a 100% CPE reduction compared to the virus control. (A) Neutralizing antibody titers of purified IgG and F(ab’) 2 of equine No.15 against SARS-CoV-2 VOC; (B) Neutralizing antibody titers of purified IgG and F(ab’) 2 of equine No.16 against SARS-CoV-2 VOC; (C) Neutralizing antibody titers of purified equine immunoglobulin of equine No.15 against SARS-CoV-2 VOI; (D) Neutralizing antibody titers of purified equine immunoglobulin of equine No.16 against SARS-CoV-2 VOI. Comparison to the wild type SARS-CoV-2 Wuhan01, the number above the column represented the fold by which the neutralizing titer of the IgG or F(ab’) 2 was weakened by the SARS-CoV-2 VOC and VOI. Samples were processed in triplicate, and error bars indicate standard error. Data are presented as the mean ± SEM. (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
Article Snippet: Next, the cells were subjected to IFA analysis by using 1,000-fold dilution of
Techniques: Activity Assay, Purification
Journal: Frontiers in Immunology
Article Title: Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
doi: 10.3389/fimmu.2023.1066730
Figure Lengend Snippet: Evaluation of the protective efficacy of purified equine immunoglobulin in a mouse model. Groups of 13 BALB/c mice were administered with IgG or F(ab’) 2 at 1 day before mouse-adapted SARS-CoV-2 (BMA8) infection or 1 dpi with BMA8. Each mouse was given 250 µg of antibody at a dose of 10 mg/kg. BALB/c mice were challenged intranasally with a lethal dose 50 LD 50 of BMA8 before treatment or after administration. The survival rate, weight change, body temperature and clinical scores of BALB/c mice were monitored daily after SARS-CoV-2 BMA8 infection. (A) Schematic diagram of the administration of equine immunoglobulin drugs and virus challenge procedure; (B) Survival rate. (C) Percent weight change. (D) Body temperature change. Body weight change of mice in a with comparison to isotype control was measured by repeated measurements two-way analysis of variance (ANOVA) with Tukey’s post hoc test. Data are mean ± s.e.m. of each experimental group. (****P < 0.0001).
Article Snippet: Next, the cells were subjected to IFA analysis by using 1,000-fold dilution of
Techniques: Purification, Infection
Journal: Frontiers in Immunology
Article Title: Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
doi: 10.3389/fimmu.2023.1066730
Figure Lengend Snippet: Blood counts in SARS-CoV-2-infected mice. The hematological values of BALB/c mice were analysed, including lymphocyte (LYM), neutrophil percentage (Neu%), monocytes (Mon), platelet count (PLT) and white blood cell count (WBC), at 3 dpi after SARS-CoV-2 BMA8 infection. Four infected mice were sacrificed at 3 dpi to collect the whole blood for blood counts test. (A) White blood cell (WBC) count; (B) neutrophil (Neu) percentage; (C) lymphocyte (LYM) percentage; (D) platelet (PLT) (E) Monocyte(Mno). Data are presented as the mean ± SEM (n=4). (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
Article Snippet: Next, the cells were subjected to IFA analysis by using 1,000-fold dilution of
Techniques: Infection, Cell Counting
Journal: Frontiers in Immunology
Article Title: Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
doi: 10.3389/fimmu.2023.1066730
Figure Lengend Snippet: Histopathological and immunohistochemistry findings in SARS-CoV-2-infected mice. The lungs and spleens were collected from the control mice infected with SARS-CoV-2 without equine immunoglobulin drug injection at 3dpi, and the lungs, spleens, livers and kidneys were harvested from recovered mice. After each tissue was embedded in paraffin, the sections were sectioned for HE staining. (A, B, E, F) Lung tissue changes of control mice were characterized by more necrotic epithelial cells (blue arrow), a small amount of neutrophil infiltration, and perivascular edema with a small amount of inflammatory cell infiltration in the local alveolar cavity (yellow arrow). (C, D, G, H) Spleen tissue changes of control mice were characterized with spotted apoptosis of lymphocytes, nuclear pyknosis and deep staining or fragmentation in the spleen nodules (black arrows), and the expansion of germinal centers (yellow arrow), scattered neutrophils mostly seen in the red pulp granulocyte infiltration (red arrow), and more brown‒yellow particles in the red pulp (blue arrow). (I-L) The basically normal structure of the lung, spleen liver, and kidney tissues were found in administration groups given equine IgG or F(ab’) 2 . The figure showed immunohistochemistry (IHC) labeling against SARS-CoV-2 N. (M) Viral antigen was not detectable in prevention group given purified IgG; (N) Viral antigen was not detectable in prevention group given purified F(ab’) 2 ; (O) Viral antigen was detected for positive in prevention control group; (P) Viral antigen was not detectable in treatment group given purified IgG; (Q) Viral antigen was not detectable in treatment group given purified IgG F(ab’) 2 ; (R) Viral antigen was detected for positive in treatment control group. (scale bar = 100 μm).
Article Snippet: Next, the cells were subjected to IFA analysis by using 1,000-fold dilution of
Techniques: Immunohistochemistry, Infection, Injection, Staining, Labeling, Purification
Journal: Frontiers in Immunology
Article Title: Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
doi: 10.3389/fimmu.2023.1066730
Figure Lengend Snippet: Evaluation of the protective efficacy of purified equine immunoglobulin in the golden hamster model. Each golden hamster was given 500 µg of antibody at a dose of 10 mg/kg. Groups of golden hamsters were infected intranasally with 1,000 TCID 50 of wild-type SARS-CoV-2 Wuhan 01 before treatment and or after administration. The survival rate and weight change of BALB/c mice were monitored daily after SARS-CoV-2 Wuhan01 infection. Four infected golden hamsters in each group were sacrificed at 3 dpi, and the turbinate and lung samples were collected to analyze the viral RNA loads by RT‒qPCR and TCID 50 , respectively. (A) Schematic diagram of the administration of equine immunoglobulin drugs and virus challenge procedure. (B) Survival rate. (C) Percent weight change; Body weight change of mice in a with comparison to isotype control was measured by repeated measurements two-way analysis of variance (ANOVA) with Tukey’s post hoc test. Data are mean ± s.e.m. of each experimental group. (D) The viral loads of turbinate were quantified by RT‒qPCR at 3 dpi in each group; (E) The viral loads of lung were quantified by RT‒qPCR at 3 dpi in each group; (F) The viral loads of turbinate were determined by TCID 50 at 3 dpi in each group; (G) The viral loads of lung were determined by TCID 50 at 3 dpi in each group. Data are presented as the mean ± SEM (n=5). (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
Article Snippet: Next, the cells were subjected to IFA analysis by using 1,000-fold dilution of
Techniques: Purification, Infection
Journal: Antiviral Research
Article Title: Pinosrtobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism
doi: 10.1016/j.antiviral.2023.105570
Figure Lengend Snippet: Antiviral activity of PSB against HCoV-OC43. (a)The structures of PSB. (b) CPE assay. HCoV-infected HRT-18 cells were cultured with or without the PSB at 72 hpi. HCoV-OC3 induced hornet's nest-like CPE in HRT-18 cells at 72 hpi (left). PSB reduced CPE without apparent cytotoxicity at 72 hpi (right). (c) Viral nucleocapsid protein analysis. HCoV-infected HRT-18 cells were cultured with DMSO or different concentrations of PSB at 48 hpi. Viral nucleocapsid protein was quantified using an antibody-based assay and compared to the DMSO-treated controls (left). Cell viability also was examined by CCK-8 assay (right). (d) Time of PSB addition study. HRT-18 cells were seeded in 24-well plates for overnight incubation and then infected with HCoV-OC43 at MOI of 5 for 2 h. 0.25%DMSO or 32 μM PSB was added to cells at −2,0, 2, 4, 6, 8 h. The supernatants were harvested and subjected to TCID50 assay at 12 hpi.Tests were performed in triplicates to calculate TCID 50 inhibition rates relative to DMSO. (e, f) TEM analysis. Under TEM, viral particles (green arrows) were detected in the DMVs of HRT-18 cells infected with HCoV-OC43 (e) and were absent from PSB treated cells (f).
Article Snippet:
Techniques: Activity Assay, Infection, Cell Culture, CCK-8 Assay, Incubation, TCID50 Assay, Inhibition
Journal: Antiviral Research
Article Title: Pinosrtobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism
doi: 10.1016/j.antiviral.2023.105570
Figure Lengend Snippet: Metabolomic analyses of DMSO (A) and PSB-treated (B) HCoV-OC43 infected cells. a. Coefficient of variation; b. 2D-PCA score plots; c. S-plot of A and B groups from the OPLS-DA model. The red dot means VIP >1.0; d. Volcano plots of differentially expressed metabolites. e. Bar plots of the top significantly up- and downregulated metabolites. f. The enrichment analysis of KEGG pathways.
Article Snippet:
Techniques: Infection
Journal: Antiviral Research
Article Title: Pinosrtobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism
doi: 10.1016/j.antiviral.2023.105570
Figure Lengend Snippet: a. Hierarchical clustering heatmap of the differential metabolites, with the degree of change marked in red (up-regulation) and blue (down-regulation).b. Compare the levels of key metabolites of 12, 13-EpOME and PGE2 in HRT-18 cells. HCoV-OC43 was incubated at MOI 0.01 with monolayers of HRT-18 cells and treated with DMSO or 32 μM PSB for 24 hpi, the cells were harvested and determined using UPLC-MS/MS based Metware database. Peak area represents relative content of 12, 13-EpOME (left) or PGE2 (right). c. The increment of HCoV-OC43 in HRT-18 cells by exogenous supplement of 200 nM 12, 13-EpOME or 100 nM PGE2 at MOI 0.05(left) or MOI 0.005(right). Fluorescence value represents viral nucleocapsid protein quantified using an antibody-based assay at 48 hpi. Error bars are shown as mean ± SD. Statistical significance was determined by one-way ANOVA multiple-group comparisons.
Article Snippet:
Techniques: Incubation, Tandem Mass Spectroscopy, Fluorescence
Journal: Antiviral Research
Article Title: Pinosrtobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism
doi: 10.1016/j.antiviral.2023.105570
Figure Lengend Snippet: a. MetaboAnalyst was carried out to analyze the pathway associated with PSB treated on HCoV-OC43 infected HRT-18 cells. Each dot represents a metabolic pathway. b. Correlation heatmap. of metabolites and gene mRNA levels. Red represents positive correlation, and white indicates negative correlation.
Article Snippet:
Techniques: Infection
Journal: bioRxiv
Article Title: Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray
doi: 10.1101/2020.03.24.006544
Figure Lengend Snippet: Coronavirus antigens on microarray.
Article Snippet: Coronavirus , OC43 , OC43 , HE , ATN39879.2 , HEK293 ,
Techniques: Microarray, Expressing, Construct